Press Releases September 17, 2025: MaaT Pharma Publishes its Half Year 2025 Results and Provides a Business Update MaaT Pharma Publishes its Half Year 2025 Results and Provides a Business Update Positive results…MaaT PharmaSeptember 17, 2025
Press Releases June 19, 2025: MaaT Pharma Provides a Business Update and Highlights Key Milestones Expected in 2025 MaaT Pharma Provides a Business Update and Highlights Key Milestones Expected in 2025 Marketing Authorization…MaaT PharmaJune 19, 2025
Press Releases June 2, 2025: MaaT Pharma Advances Toward Commercialization And Submits Marketing Authorization Application to the European Medicines Agency (EMA) for Xervyteg® (MaaT013) in Acute Graft-versus-Host Disease MaaT Pharma Advances Toward Commercialization And Submits Marketing Authorization Application to the European Medicines Agency…MaaT PharmaJune 2, 2025
Press Releases May 13, 2025: MaaT Pharma Provides Business Update and Reports Financial Results for the First Quarter 2025 MaaT Pharma Provides Business Update and Reports Financial Results for the First Quarter 2025 Positive…MaaT PharmaMay 13, 2025